| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Progyny (NASDAQ:PGNY) reported its Q4 earnings results on Tuesday, February 27, 2024 at 04:03 PM.
Here's what investors need to know about the announcement.
Progyny beat estimated earnings by 30.0%, reporting an EPS of $0.13 versus an estimate of $0.1.
Revenue was up $55.62 million from the same period last year.
Last quarter the company beat on EPS by $0.04 which was followed by a 8.0% drop in the share price the next day.
Here's a look at Progyny's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.12 | 0.10 | 0.07 | 0.01 |
| EPS Actual | 0.16 | 0.15 | 0.18 | 0.03 |
| Revenue Estimate | 271.19M | 261.91M | 246.40M | 211.78M |
| Revenue Actual | 280.89M | 279.37M | 258.39M | 214.32M |
To track all earnings releases for Progyny visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: PGNY
